CUTERA INC
CUTERA INC
Action · US2321091082 · CUTR · A0B9QG (XNAS)
Aperçu
Résumé de la Note des Analystes
gauge-img
Conserver
Achat fort
Achat
Conserver
Vente
Vente forte
0
4
5
0
0
Pas de cours
n/a
Flottant et Liquidité des Actions
Flottant Libre 99,15 %
Actions en Flottant 20,01 M
Actions en Circulation 20,19 M
Profil de l'entreprise pour CUTERA INC Action
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
Obtenez des informations actualisées de finAgent sur CUTERA INC

Données de l'entreprise

Nom CUTERA INC
Société Cutera, Inc.
Symbole CUTR
Site web https://www.cutera.com
Marché d'origine XNAS NASDAQ
WKN A0B9QG
ISIN US2321091082
Type de titre Action
Secteur Healthcare
Industrie Medical - Devices
PDG Taylor C. Harris
Pays États-Unis d'Amérique
Devise USD
Employés 0,4 T
Adresse 3240 Bayshore Boulevard, 94005 Brisbane
Date d'introduction en bourse 2004-03-31

Symboles boursiers

Nom Symbole
Frankfurt TJ9.F
NASDAQ CUTR
Autres actions
Les investisseurs qui détiennent CUTERA INC ont également les actions suivantes dans leur portefeuille :
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CINTAS CORP
CINTAS CORP Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
INTEL CORP
INTEL CORP Action
INVESTEC BANK PLC EUR IMPALA KO NTS CAR 26/03/24
INVESTEC BANK PLC EUR IMPALA KO NTS CAR 26/03/24 Obligation
ISHARES EVOLVED U.S. DISCRETIONARY SPENDING ETF
ISHARES EVOLVED U.S. DISCRETIONARY SPENDING ETF ETF
MICROSOFT CORP
MICROSOFT CORP Action
MSF GL.OPP.-WORLDSELECT B
MSF GL.OPP.-WORLDSELECT B Fonds
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
WILLAMETTE VALLEY VINEYARDS INC
WILLAMETTE VALLEY VINEYARDS INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025